Nautilus Biotechnology, Inc. (NAUT) NASDAQ

1.77

-0.12(-6.35%)

Updated at November 14 10:48AM

Currency In USD

Valuation

Market Cap210.72M
Enterprise Value213.55M
P/E Ratio-3.56
PEG Ratio-0.92
Price/Sales Ratio23.29
Price/Book Ratio1.32
Enterprise/Revenue23.61
Enterprise/EBITDA-3.53

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-6.54
Operating Margin-7.44

Management Effectiveness

Return On Assets-0.31
Return On Equity-0.33

Income Statement

Revenue0
Revenue/Share0.08
Gross Profit-6.35M
EBITDA-64.43M
Net Income-70.78M
Diluted EPS-0.56

Balance Sheet

Total Cash131.43M
Total Cash/Share1.04
Total Debt27M
Total Debt/Equity0.16
Current Ratio14.95
Book Value Per Share1.34

Price History

52-Week Change-28.05
52-Week High2.51
52-Week Low0.62
Moving Average 50 Days1.07
Moving Average 200 Days0.95

Statistics

Average Volume477,829
Shares Outstanding126.31M
% Held by Institutions7.14

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A